Supreme Court guides Tribunal on confidentiality in customs cases

The Supreme Court remanded the case to the Tribunal with directions on handling confidentiality claims under Rule 7 of the Customs Tariff Rules. The Tribunal emphasized the need for justifying confidentiality on a case-by-case basis. It ruled that certain information, including Normal Value (NV), Export Price (EP), and Non-Injurious Price (NIP), should be disclosed unless specific circumstances warrant confidentiality. The Tribunal also ordered the Domestic Industry to reconcile conflicting data on installed capacity and disclose relevant non-confidential information within a week for further proceedings.

---

---

Issues Involved:
1. Confidentiality under Rule 7 of the Customs Tariff (Identification, Assessment, and Collection of Anti-dumping Duty on Dumped Articles and for Determination of Injury) Rules, 1995.
2. Disclosure of Normal Value (NV) and Export Price (EP).
3. Basis of Injury.
4. Other factors causing injury.
5. Disclosure of Non-Injurious Price (NIP).
6. Installed capacity of the Domestic Industry during the Period of Investigation (POI).

Detailed Analysis:

1. Confidentiality under Rule 7:
The Supreme Court remanded the appeals to the Tribunal with directions on handling confidentiality claims under Rule 7. The Tribunal emphasized that confidentiality should not be automatically assumed and must be justified on a case-by-case basis. The Designated Authority (DA) must be satisfied about the confidentiality of the material and provide non-confidential summaries, or reasons why summarization is not possible. The Tribunal has the liberty to decide whether material should be kept confidential.

2. Disclosure of Normal Value (NV) and Export Price (EP):
The appellants argued that the actual figures of NV and EP should be disclosed and cannot be treated as confidential. They also contended that the basis and method by which the DA arrived at these figures should be non-confidential. The DA opposed this, fearing that disclosure might compromise individual exporter data. The Tribunal concluded that NV and EP are figures worked out by the DA and do not relate to specific transactions, hence cannot be treated as confidential. The basis and method of arriving at these figures, including components like price of materials and cost of energy, should also be disclosed unless they pertain to a particular manufacturer.

3. Basis of Injury:
Appellants contended that information related to injury factors should not be confidential. The respondents agreed but highlighted issues with multi-product companies and POI less than a year. The Tribunal ruled that all information that would be available in a balance sheet for a single-product company should be disclosed, regardless of whether the company is multi-product or the POI is less than a year. This ensures a meaningful challenge against the final finding and notification.

4. Other Factors Causing Injury:
Appellants argued that factors other than dumped imports causing injury should be non-confidential. The respondents did not dispute this claim. The Tribunal agreed and held that all such factors should be treated as non-confidential.

5. Disclosure of Non-Injurious Price (NIP):
Appellants contended that the NIP figure and the methodology for arriving at it should be disclosed. The respondents opposed disclosing confidential details and figures. The Tribunal ruled that the NIP figure, methodology, and factors considered for arriving at NIP should be disclosed, except for details hit by the rule of confidentiality.

6. Installed Capacity of the Domestic Industry during POI:
There was a specific dispute regarding the actual installed capacity of the Domestic Industry during POI, with conflicting figures of 7.5 million KMS and 10 million KMS. The Tribunal directed the Domestic Industry to reconcile and disclose the correct information.

Conclusion:
The Tribunal directed the DA to disclose the actual amounts of NV, EP, and NIP, along with other non-confidential information. The Domestic Industry was also directed to disclose relevant product-specific information that would appear in a balance sheet if the product in question was the only product. Disclosure was to be made within one week, with further hearings scheduled.

---